Cases & Deals

Maverick Capital invests in Caribou Biosciences

Clients Maverick Capital Ventures LLC

Jones Day represented Maverick Capital Ventures LLC in connection with its purchase of Series B Convertible Preferred Stock in a private placement by Caribou Biosciences, Inc., a developer of CRISPR-Cas technologies for genome engineering. Anterra Capital, Heritage Group, Pontifax AgTech, F-Prime Capital Partners, Novartis, Mission Bay Capital, and 5 Prime Ventures acted as co-investors in the $30 million investment round.